Jasper Therapeutics, Inc. (JSPR)
0.51
+0.01
(+2.91%)
USD |
NASDAQ |
Oct 23, 16:00
0.52
+0.01
(+1.96%)
After-Hours: 20:00
Jasper Therapeutics Net Income (Quarterly) : -2.76M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.76M |
| March 31, 2026 | -1.174M |
| December 31, 2025 | -9.101M |
| September 30, 2025 | -18.74M |
| June 30, 2025 | -26.72M |
| March 31, 2025 | -21.24M |
| December 31, 2024 | -24.32M |
| September 30, 2024 | -18.64M |
| June 30, 2024 | -14.58M |
| March 31, 2024 | -13.73M |
| December 31, 2023 | -16.58M |
| September 30, 2023 | -17.54M |
| June 30, 2023 | -16.08M |
| March 31, 2023 | -14.26M |
| Date | Value |
|---|---|
| December 31, 2022 | -13.21M |
| September 30, 2022 | -11.86M |
| June 30, 2022 | -10.40M |
| March 31, 2022 | -2.207M |
| December 31, 2021 | -9.057M |
| September 30, 2021 | -3.412M |
| June 30, 2021 | -8.414M |
| March 31, 2021 | -9.754M |
| December 31, 2020 | -9.987M |
| September 30, 2020 | -10.82M |
| June 30, 2020 | -3.432M |
| March 31, 2020 | 1.429M |
| September 30, 2019 | -0.001M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 2.76M |
| EPS Diluted (Quarterly) | -0.0962 |
| Enterprise Value | 6.860M |
| Earnings Yield | -310.0% |
| Normalized Earnings Yield | -407.16 |